Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Emmanuele Crespan

Showing results (61-70 of 92) with videos related to

Pageof 10
Sort By:
Chemmedchem|February 26, 2013
A combination strategy to inhibit Pim-1: synergism between noncompetitive and ATP-competitive inhibitorsMattia Mori, Cristina Tintori, Robert Selwyne Arul Christopher, et al.
Nucleic Acids Research|August 14, 2018
p15PAF binding to PCNA modulates the DNA sliding surfaceMatteo De March, Susana Barrera-Vilarmau, Emmanuele Crespan, et al.
Journal of Medicinal Chemistry|February 9, 2008
Structure-based optimization of pyrazolo[3,4-d]pyrimidines as Abl inhibitors and antiproliferative agents toward human leukemia cell linesFabrizio Manetti, Chiara Brullo, Matteo Magnani, et al.
European Journal of Medicinal Chemistry|August 11, 2019
Identification of a new family of pyrazolo[3,4-d]pyrimidine derivatives as multitarget Fyn-Blk-Lyn inhibitors active on B- and T-lymphoma cell linesAnna Lucia Fallacara, Raffaele Passannanti, Mattia Mori, et al.
European Journal of Medicinal Chemistry|October 15, 2024
Applying molecular hybridization to design a new class of pyrazolo[3,4-d]pyrimidines as Src inhibitors active in hepatocellular carcinomaSalvatore Di Maria, Raffaele Passannanti, Federica Poggialini, et al.
Journal of Medicinal Chemistry|March 30, 2011
Design, synthesis, biological activity, and ADME properties of pyrazolo[3,4-d]pyrimidines active in hypoxic human leukemia cells: a lead optimization studyMarco Radi, Elena Dreassi, Chiara Brullo, et al.
Journal of Medicinal Chemistry|June 17, 2014
Exploring the role of 2-chloro-6-fluoro substitution in 2-alkylthio-6-benzyl-5-alkylpyrimidin-4(3H)-ones: effects in HIV-1-infected cells and in HIV-1 reverse transcriptase enzymesDante Rotili, Domenico Tarantino, Maxim B Nawrozkij, et al.
Journal of Medicinal Chemistry|June 4, 2015
Discovery of Multitarget Antivirals Acting on Both the Dengue Virus NS5-NS3 Interaction and the Host Src/Fyn KinasesPaolo Vincetti, Fabiana Caporuscio, Suzanne Kaptein, et al.
Journal of Medicinal Chemistry|June 11, 2013
Design, synthesis, and biological evaluation of pyrazolo[3,4-d]pyrimidines active in vivo on the Bcr-Abl T315I mutantMarco Radi, Cristina Tintori, Francesca Musumeci, et al.
Journal of Medicinal Chemistry|December 13, 2005
Parallel solution-phase and microwave-assisted synthesis of new S-DABO derivatives endowed with subnanomolar anti-HIV-1 activityFabrizio Manetti, José A Esté, Imma Clotet-Codina, et al.
Pageof 10

Showing results (61-70 of 92) with videos related to

Sort By:
Pageof 10
Chemmedchem|February 26, 2013
A combination strategy to inhibit Pim-1: synergism between noncompetitive and ATP-competitive inhibitorsMattia Mori, Cristina Tintori, Robert Selwyne Arul Christopher, et al.
Nucleic Acids Research|August 14, 2018
p15PAF binding to PCNA modulates the DNA sliding surfaceMatteo De March, Susana Barrera-Vilarmau, Emmanuele Crespan, et al.
Journal of Medicinal Chemistry|February 9, 2008
Structure-based optimization of pyrazolo[3,4-d]pyrimidines as Abl inhibitors and antiproliferative agents toward human leukemia cell linesFabrizio Manetti, Chiara Brullo, Matteo Magnani, et al.
European Journal of Medicinal Chemistry|August 11, 2019
Identification of a new family of pyrazolo[3,4-d]pyrimidine derivatives as multitarget Fyn-Blk-Lyn inhibitors active on B- and T-lymphoma cell linesAnna Lucia Fallacara, Raffaele Passannanti, Mattia Mori, et al.
European Journal of Medicinal Chemistry|October 15, 2024
Applying molecular hybridization to design a new class of pyrazolo[3,4-d]pyrimidines as Src inhibitors active in hepatocellular carcinomaSalvatore Di Maria, Raffaele Passannanti, Federica Poggialini, et al.
Journal of Medicinal Chemistry|March 30, 2011
Design, synthesis, biological activity, and ADME properties of pyrazolo[3,4-d]pyrimidines active in hypoxic human leukemia cells: a lead optimization studyMarco Radi, Elena Dreassi, Chiara Brullo, et al.
Journal of Medicinal Chemistry|June 17, 2014
Exploring the role of 2-chloro-6-fluoro substitution in 2-alkylthio-6-benzyl-5-alkylpyrimidin-4(3H)-ones: effects in HIV-1-infected cells and in HIV-1 reverse transcriptase enzymesDante Rotili, Domenico Tarantino, Maxim B Nawrozkij, et al.
Journal of Medicinal Chemistry|June 4, 2015
Discovery of Multitarget Antivirals Acting on Both the Dengue Virus NS5-NS3 Interaction and the Host Src/Fyn KinasesPaolo Vincetti, Fabiana Caporuscio, Suzanne Kaptein, et al.
Journal of Medicinal Chemistry|June 11, 2013
Design, synthesis, and biological evaluation of pyrazolo[3,4-d]pyrimidines active in vivo on the Bcr-Abl T315I mutantMarco Radi, Cristina Tintori, Francesca Musumeci, et al.
Journal of Medicinal Chemistry|December 13, 2005
Parallel solution-phase and microwave-assisted synthesis of new S-DABO derivatives endowed with subnanomolar anti-HIV-1 activityFabrizio Manetti, José A Esté, Imma Clotet-Codina, et al.
Pageof 10